By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has received a letter from Nasdaq saying that the firm's shares do not currently meet the exchange's requirements for minimum stockholders' equity.

The Melbourne, Australia-based firm said that the non-compliance was the result of its reported stockholders' equity as of Dec. 31, 2009 falling below the $10 million threshold as required by Nasdaq's rules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.